MedTrace Logo

Spectral Precise Image Study for Brain Tumors

NCT07620470 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2026-06-02

No results posted yet for this study

Summary

The goal of this observational study is to explore the image quality of spectral CT deep learning reconstruction technology (Spectral Precise Image) of patients with confirmed brain tumors.

The main question it aims to answer is:

The Image Quality (IQ) and diagnostic confidence of Spectral Precise Image reconstructions

Conditions

Interventions

DEVICE

This is an observational data collection study

This is an observational data collection study

Sponsors & Collaborators

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER

  • Philips Clinical & Medical Affairs Global

    lead INDUSTRY

Principal Investigators

  • Jing Wang · 1277 Jiefang Avenue, Wuhan, Hubei Province, P. R. China

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-28
Primary Completion
2026-08-30
Completion
2026-12-31
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07620470 on ClinicalTrials.gov